CAPR
Price
$11.15
Change
+$0.97 (+9.53%)
Updated
Jun 27 closing price
Capitalization
509.64M
38 days until earnings call
GENFF
Price
$0.01
Change
-$0.00 (-0.00%)
Updated
Jun 23 closing price
Capitalization
4.51M
Interact to see
Advertisement

CAPR vs GENFF

Header iconCAPR vs GENFF Comparison
Open Charts CAPR vs GENFFBanner chart's image
Capricor Therapeutics
Price$11.15
Change+$0.97 (+9.53%)
Volume$2.64M
Capitalization509.64M
Genflow Biosciences
Price$0.01
Change-$0.00 (-0.00%)
Volume$1K
Capitalization4.51M
CAPR vs GENFF Comparison Chart in %
Loading...
CAPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GENFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CAPR vs. GENFF commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAPR is a Buy and GENFF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (CAPR: $11.15 vs. GENFF: $0.01)
Brand notoriety: CAPR and GENFF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CAPR: 87% vs. GENFF: 24%
Market capitalization -- CAPR: $509.64M vs. GENFF: $4.51M
CAPR [@Biotechnology] is valued at $509.64M. GENFF’s [@Biotechnology] market capitalization is $4.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CAPR’s FA Score shows that 0 FA rating(s) are green whileGENFF’s FA Score has 0 green FA rating(s).

  • CAPR’s FA Score: 0 green, 5 red.
  • GENFF’s FA Score: 0 green, 5 red.
According to our system of comparison, CAPR is a better buy in the long-term than GENFF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CAPR’s TA Score shows that 6 TA indicator(s) are bullish while GENFF’s TA Score has 2 bullish TA indicator(s).

  • CAPR’s TA Score: 6 bullish, 4 bearish.
  • GENFF’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, CAPR is a better buy in the short-term than GENFF.

Price Growth

CAPR (@Biotechnology) experienced а +34.99% price change this week, while GENFF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

CAPR is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CAPR($510M) has a higher market cap than GENFF($4.51M). CAPR YTD gains are higher at: -19.203 vs. GENFF (-81.095).
CAPRGENFFCAPR / GENFF
Capitalization510M4.51M11,301%
EBITDA-55.78MN/A-
Gain YTD-19.203-81.09524%
P/E RatioN/AN/A-
Revenue17.4MN/A-
Total Cash145MN/A-
Total Debt1.25MN/A-
FUNDAMENTALS RATINGS
CAPR: Fundamental Ratings
CAPR
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
67
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CAPRGENFF
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
40%
Momentum
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
50%
MACD
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 4 days ago
33%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
44%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
44%
Advances
ODDS (%)
Bullish Trend 4 days ago
85%
N/A
Declines
ODDS (%)
Bearish Trend 11 days ago
85%
N/A
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 4 days ago
24%
View a ticker or compare two or three
Interact to see
Advertisement
CAPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GENFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HILVX22.750.09
+0.40%
Harbor Large Cap Value Inv
ODINX83.710.21
+0.25%
Invesco Discovery R
SSQSX16.65N/A
N/A
State Street Instl Small-Cap Equity Svc
FLIAX10.36N/A
N/A
First Sentier American Listed Infras Ins
TMLAX8.90-0.01
-0.11%
Transamerica Energy Infrastructure A

CAPR and

Correlation & Price change

A.I.dvisor tells us that CAPR and SNDX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CAPR and SNDX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CAPR
1D Price
Change %
CAPR100%
+9.53%
SNDX - CAPR
32%
Poorly correlated
-2.80%
WVE - CAPR
32%
Poorly correlated
-5.12%
CORT - CAPR
30%
Poorly correlated
-1.49%
ABEO - CAPR
30%
Poorly correlated
-2.54%
IMNM - CAPR
29%
Poorly correlated
-0.23%
More

GENFF and

Correlation & Price change

A.I.dvisor tells us that GENFF and OTLK have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GENFF and OTLK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GENFF
1D Price
Change %
GENFF100%
N/A
OTLK - GENFF
25%
Poorly correlated
-8.57%
ENTO - GENFF
25%
Poorly correlated
-12.87%
CAPR - GENFF
25%
Poorly correlated
+9.53%
APLIF - GENFF
24%
Poorly correlated
-1.90%
TOVX - GENFF
24%
Poorly correlated
-2.32%
More